RES-701-1, a novel and selective endothelin type B receptor antagonist produced by streptomyces sp. RE-701. II. Determination of the primary sequence

32Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

The structure of RES-701-1, a novel microbial endothelin type B receptor antagonist, was determined. Protein chemical data and FAB-MS have identified RES-701-1 to be a cyclic polypeptide consisting of 16 common L-amino acids. This compound is so stable against proteolysis that its enzymatic digestion under standard conditions proved to be very difficult. Therefore, the primary sequence of RES-701-1 was determined by the application of advanced protein chemical methods to be Gly1-Asn2-Trp3-His4-Gly5-Thr6-Ala7-Pro8-Asp9-Trp10-Phe11-Phep-Asnp-Tyrp-Tyr15-Trp16. The compound is cyclized between the β-carboxyl group of Asp9 and the α-amino group of Gly1. © 1994, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Yamasaki, M., Yano, K., Yoshida, M., Matsuda, Y., & Yamaguchi, K. (1994). RES-701-1, a novel and selective endothelin type B receptor antagonist produced by streptomyces sp. RE-701. II. Determination of the primary sequence. The Journal of Antibiotics, 47(3), 276–280. https://doi.org/10.7164/antibiotics.47.276

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free